DK617189A - Anvendelse af bis(3,5-di-t-butyl-4-hydroxy-phenylthio)-methan til fremstilling af et laegemiddel mod atherosclerose og hypercholesterolaemi - Google Patents

Anvendelse af bis(3,5-di-t-butyl-4-hydroxy-phenylthio)-methan til fremstilling af et laegemiddel mod atherosclerose og hypercholesterolaemi Download PDF

Info

Publication number
DK617189A
DK617189A DK617189A DK617189A DK617189A DK 617189 A DK617189 A DK 617189A DK 617189 A DK617189 A DK 617189A DK 617189 A DK617189 A DK 617189A DK 617189 A DK617189 A DK 617189A
Authority
DK
Denmark
Prior art keywords
bis
butyl
hypercholesterolaemia
methan
phenylthio
Prior art date
Application number
DK617189A
Other languages
Danish (da)
English (en)
Other versions
DK617189D0 (da
Inventor
Simon Jen Tan Mao
Richard Lee Jackson
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK617189D0 publication Critical patent/DK617189D0/da
Publication of DK617189A publication Critical patent/DK617189A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/065—Diphenyl-substituted acyclic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK617189A 1988-12-08 1989-12-07 Anvendelse af bis(3,5-di-t-butyl-4-hydroxy-phenylthio)-methan til fremstilling af et laegemiddel mod atherosclerose og hypercholesterolaemi DK617189A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/281,433 US4900757A (en) 1988-12-08 1988-12-08 Hypocholesterolemic and antiatherosclerotic uses of bix(3,5-di-tertiary-butyl-4-hydroxyphenylthio)methane

Publications (2)

Publication Number Publication Date
DK617189D0 DK617189D0 (da) 1989-12-07
DK617189A true DK617189A (da) 1990-06-09

Family

ID=23077273

Family Applications (1)

Application Number Title Priority Date Filing Date
DK617189A DK617189A (da) 1988-12-08 1989-12-07 Anvendelse af bis(3,5-di-t-butyl-4-hydroxy-phenylthio)-methan til fremstilling af et laegemiddel mod atherosclerose og hypercholesterolaemi

Country Status (12)

Country Link
US (1) US4900757A (cs)
EP (1) EP0372542B1 (cs)
JP (1) JP2811210B2 (cs)
KR (1) KR0150631B1 (cs)
AT (1) ATE81451T1 (cs)
AU (1) AU619926B2 (cs)
DE (1) DE68903215T2 (cs)
DK (1) DK617189A (cs)
ES (1) ES2052871T3 (cs)
GR (1) GR3006001T3 (cs)
IE (1) IE62820B1 (cs)
ZA (1) ZA899251B (cs)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959392A (en) * 1989-07-24 1990-09-25 Merrell Dow Pharmaceuticals Inc. Method of treating diabetes mellitus
US5122542A (en) * 1990-06-19 1992-06-16 Merrell Dow Pharmaceuticals Inc. Hypotriglyceridemic use of certain bis (3,5-di-alkyl-4-hydroxyphenylthio)methanes
AU651873B2 (en) * 1991-03-18 1994-08-04 Merrell Dow Pharmaceuticals Inc. Method of inhibiting the progressive development of diabetes mellitus
US5411741A (en) * 1993-07-29 1995-05-02 Zaias; Nardo Method and composition for skin depigmentation
HU220761B1 (hu) * 1993-12-10 2002-05-28 Merrell Pharmaceuticals Inc. 2,6-Dialkil-4-szilil-helyettesített fenolok alkalmazása szérum koleszterinszint csökkentésére használható gyógyszerkészítmények előállítására
US5677291A (en) * 1993-12-10 1997-10-14 Hoechst Marion Roussel, Inc. Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
RU2235541C2 (ru) * 1994-10-04 2004-09-10 Эмори Юниверсити Лечение атеросклероза и других сердечно-сосудистых и воспалительных заболеваний
US5795876A (en) * 1996-04-30 1998-08-18 Hoechst Marion Rousssel, Inc. Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2, 6-di-alkyl-4-silyl-phenols
US5608095A (en) * 1996-04-30 1997-03-04 Hoechst Marion Roussel, Inc. Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
US6114572A (en) * 1996-11-20 2000-09-05 Hoechst Marion Roussel, Inc. Substituted phenols and thiophenols useful as antioxidant agents
US6121463A (en) * 1997-06-24 2000-09-19 Hoechst Marion Roussel, Inc. Alkyl-4-silylheterocyclic phenols and thiophenols useful as antioxidant agents
US6133467A (en) * 1997-06-25 2000-10-17 Hoechst Marion Roussel, Inc. 2,6-di-t-butyl-4-[(dimethyl-4-methoxyphenylsilyl)-methyl-oxy]phenol and 2,6-di-t-butyl-4-[(dimethyl-2-methoxy-phenylsilyl)methyloxy]phenol
EG26979A (en) 2000-12-21 2015-03-01 Astrazeneca Ab Chemical compounds
GB0121337D0 (en) 2001-09-04 2001-10-24 Astrazeneca Ab Chemical compounds
GB0121621D0 (en) 2001-09-07 2001-10-31 Astrazeneca Ab Chemical compounds
GB0121622D0 (en) 2001-09-07 2001-10-31 Astrazeneca Ab Chemical compounds
BRPI0212346B1 (pt) 2001-09-08 2016-02-02 Albireo Ab Compostos derivados de benzotiadiazepina ou um sal farmaceuticamente aceitável do mesmo com efeito inibidor de transporte de ácido de bile ileal, processo para a preparação dos mesmos, uso destes, e, composição farmacêutica.
GB0201850D0 (en) * 2002-01-26 2002-03-13 Astrazeneca Ab Therapeutic treatment
GB0209467D0 (en) 2002-04-25 2002-06-05 Astrazeneca Ab Chemical compounds
GB0213669D0 (en) 2002-06-14 2002-07-24 Astrazeneca Ab Chemical compounds
GB0304194D0 (en) 2003-02-25 2003-03-26 Astrazeneca Ab Chemical compounds
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
SG190029A1 (en) 2010-11-04 2013-06-28 Albireo Ab Ibat inhibitors for the treatment of liver diseases
JO3301B1 (ar) 2013-04-26 2018-09-16 Albireo Ab تعديلات بلورية على إيلوبيكسيبات
KR20220082931A (ko) 2014-06-25 2022-06-17 이에이 파마 가부시키가이샤 고형 제제 및 그의 착색 방지 또는 착색 감소 방법
EP3012252A1 (en) 2014-10-24 2016-04-27 Ferring BV Crystal modifications of elobixibat
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
US10786529B2 (en) 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
CA3071285A1 (en) 2017-08-09 2019-02-14 Albireo Ab Cholestyramine granules, oral cholestyramine formulations and use thereof
US10793534B2 (en) 2018-06-05 2020-10-06 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
WO2019234077A1 (en) 2018-06-05 2019-12-12 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
PE20210136A1 (es) 2018-06-20 2021-01-21 Albireo Ab Formulacion farmaceutica de odevixibat
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
PE20212251A1 (es) 2019-02-06 2021-11-24 Albireo Ab Compuestos de benzotiadiazepina y su uso como moduladores del acido biliar
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
EP4069361B1 (en) 2019-12-04 2024-01-03 Albireo AB Benzothia(di)azepine compounds and their use as bile acid modulators
EP4069247B1 (en) 2019-12-04 2025-03-26 Albireo AB Benzothiadiazepine compounds and their use as bile acid modulators
AU2020397448A1 (en) 2019-12-04 2022-05-26 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
CA3158276A1 (en) 2019-12-04 2021-06-10 Per-Goran Gillberg Benzothia(di)azepine compounds and their use as bile acid modulators
JP7748451B2 (ja) 2020-08-03 2025-10-02 アルビレオ・アクチボラグ ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
EP4243831A1 (en) 2020-11-12 2023-09-20 Albireo AB Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
BR112023010799A2 (pt) 2020-12-04 2023-10-03 Albireo Ab Compostos de benzotia(di)azepina e seus usos como moduladores de ácidos biliares
TW202313579A (zh) 2021-06-03 2023-04-01 瑞典商艾爾比瑞歐公司 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154666B (nl) * 1967-05-11 1977-10-17 Dow Chemical Co Werkwijze ter bereiding van een hypocholesteremisch preparaat, alsmede de onder toepassing van deze werkwijze verkregen, gevormde preparaten.
GB1199871A (en) * 1967-05-11 1970-07-22 Consolidation Coal Co Improvements in or relating to Sulfur-Containing Bisphenols
US3862332A (en) * 1967-05-11 1975-01-21 Dow Chemical Co Method of lowering serum cholesterol
US3576883A (en) * 1969-06-30 1971-04-27 Consolidation Coal Co Alkylidenedithiobisphenols

Also Published As

Publication number Publication date
ZA899251B (en) 1990-09-26
EP0372542A2 (en) 1990-06-13
IE893922L (en) 1990-06-08
KR0150631B1 (ko) 1998-10-15
JPH02202817A (ja) 1990-08-10
AU4588489A (en) 1990-06-14
JP2811210B2 (ja) 1998-10-15
EP0372542B1 (en) 1992-10-14
GR3006001T3 (cs) 1993-06-21
IE62820B1 (en) 1995-03-08
KR900009079A (ko) 1990-07-02
ES2052871T3 (es) 1994-07-16
EP0372542A3 (en) 1990-10-17
ATE81451T1 (de) 1992-10-15
DE68903215T2 (de) 1993-04-22
DK617189D0 (da) 1989-12-07
US4900757A (en) 1990-02-13
AU619926B2 (en) 1992-02-06
DE68903215D1 (de) 1992-11-19

Similar Documents

Publication Publication Date Title
DK617189A (da) Anvendelse af bis(3,5-di-t-butyl-4-hydroxy-phenylthio)-methan til fremstilling af et laegemiddel mod atherosclerose og hypercholesterolaemi
FR2626180B1 (fr) Cartouche, appareil et procedes d'hemodiafiltration
DK264888D0 (da) Fremgangsmaade til stabilisering af vanadiumtetrachlorid mod dekomponering og staliliseret vanadiumtetrachloridsammensaetning
FR2621245B1 (fr) Table d'operation orthopedique pour membres et notamment pour membres inferieurs
DE58900119D1 (de) Chirurgisches instrument zum einsetzen von hueftpfannen-prothesen.
NO891896L (no) Fremgangsmaate og innretning for behandling av medisinsk spesialavfall.
NO893769D0 (no) Fremgangsmaate for behandling av naturgass.
DK69587A (da) Forbedringer i og angaaende et dispenseringsapparattil en dispenseringsbeholder med trykgas
DK268189D0 (da) Aromatiske forbindelser og fremgangsmaader til fremstilling deraf
NO902767D0 (no) Fremgangsmaate og innretning for behandling av en fiberstoff-vaeske-blanding.
ATE81662T1 (de) Polyester.
NO880179D0 (no) Polymerkomplekser, fremgangsmaate for fremstilling av disse, og farmasoeytiske midler inneholdende disse.
DK0476113T3 (da) Lægemiddel til behandling af hyperlipidæmi og/eller atherosklerose
IL87566A0 (en) Medical composition for the treatment of diabetes comprising a benzamide derivative
FR2656138B1 (fr) Appareil combine d'enseignement et d'exercice dentaires.
DK431489D0 (da) Lipoprotein i (ompi) af pseudomonas aeruginosa, dets fremstilling og anvendelse
NO902949D0 (no) Fiberoptisk kanisteradhesiv og anvendelse derav.
FR2710539B1 (fr) Ensemble d'aiguille chirurgicale.
ES2019053A4 (es) Centro quirurgico modular ambulatorio.
DK213988D0 (da) Dihydropyridinforbindelser samt medisinsk anvendelse af disse og beslaegtede forbindelser og farmaceutiske praeparater indholdende disse.
DK36387A (da) Desinficerende og steriliserende praeparat
DK226688D0 (da) Middel til behandling og forebyggelse af asthma
DE68903543D1 (de) Behandlungsmaterial enthaltende zwischenwirbel-prothese.
CY2019A (en) The use of bmy 14802 in the treatment of anxiety in benzodiazepine-withdrawn patients
DK641189D0 (da) Praeparat til behandling af glaucom og fremgangsmaade til fremstilling af et saadant praeparat

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment